Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zurex PharmAgra has introduced ZuraLac family of teat treatments comprising novel antimicrobial formulation.
Subscribe to our email newsletter
The ZuraLac product is a non-iodine based sanitizer targeting dairy mastitis and has been developed to prevent healthcare acquired infections in hospitals and healthcare settings.
The company said the product has been proven to be effective against mastitis causing organisms and shows better teat end conditioning in cold weather conditions when compared to iodine based products.
In addition, the formulation also provides a visual indicator of antimicrobial activity for the dairy producer.